Michaelis-Menten pharmacokinetic parameters for theophylline were estimated in a three-month infant following an accidental overdose of intravenous aminophylline. Fitting of time-concentration data was performed using nonlinear regression with MKMODEL. A mixed order elimination model was superior to a first order model. Parameter estimates were standardized to a 70 kg human using an allometric power model. Parameter estimates (SE) were: maximum rate of metabolism (Vmax) 71(42) mg.h -1 , Michaelis-Menten constant (Km) 32.3 (33.5) mg.l -1 , volume of distribution (Vd) 46.9 (2.6) l. This Michaelis-Menten constant is lower than that reported for adults and consequently non-linear elimination will occur at lower plasma concentrations in infants than in adults.
Metabolism of theophylline varies with age [1] [2] [3] . Elimination in adults is mixed order at high concentrations due to saturation of metabolic pathways 4, 5 . The pharmacokinetic parameters of theophylline clearance in an infant have not been described. We had the opportunity to study the pharmacokinetics of theophylline in an infant following an accidental drug overdose.
The clearance of theophylline at different ages has traditionally been reported as directly proportional to body weight. We have reviewed these literature estimates using an allometric power model.
PATIENT AND METHODS

Case Report
A three-month, 6 kg male infant suffering bronchiolitis was transferred to a paediatric intensive care facility (PICU) from a provincial hospital. He was managed with supplemental oxygen via a naso-pharyngeal catheter 6 and required no ventilator support. A consistent feature of his illness during the PICU stay was sinus tachycardia above 200 min -1 . A plasma theophylline concentration soon after admission was 112 mg.l -1 . Subsequent investigation revealed this child to have received 100 mg.kg -1 aminophylline (theophylline 80 mg.kg -1 ) intravenously ten hours earlier. The infant showed no other manifestations of toxicity aside from tachycardia. He was managed conservatively and made an unremarkable recovery.
Theophylline Analysis
Theophylline concentrations were determined by fluorescence polarization immunoassay using the Abbott AxSym immunoanalyser system (Abbott Laboratories, Abbott Park, IL 60064, U.S.A.). The instrument was operated in accordance with the manufacturers' instructions. The controls were Dade TDM Level 1 and Dade TDM Level 2 (Baxter Diagnostics, Deerfield, IL 60015, U.S.A.). Estimates of between day precision were 10.1±0.5 mg.l -1 (CV 30%) for Level 1 and 22.0±1.1 mg.l -1 (CV 2.5%) for Level 2, obtained from control data collected over the time frame which included the patient measurements. Our mean values agreed well with the accepted ranges quoted by Baxter, 9.0-10.8 mg.l -1 (Level 1) and 20.9-23.0 mg.l -1 (Level 2).
Pharmacokinetic Modelling
Plasma theophylline concentrations were measured over a 70 hour period after administration. A one-compartment model with mixed order elimination was used to estimate the maximum rate of metabolism (Vmax), the Michaelis-Menten constant (Km) and volume of distribution (Vd). Fitting was performed using non-linear regression with MKMODEL 7 . In this process improvements on the initial estimates are sought by a reiterative technique. In each iteration the parameters are adjusted in turn and the "goodness of fit" is calculated. A change which leads to an improved fit is regarded as being in the direction of the solution.
The mixed order model for rate of change of concentration at time t, (dC(t)/dt) was:
Vd mg.l -1 .h -1 C is the plasma theophylline concentration (mg.l -1 ), Vd is the volume of distribution (l), Dose/TK0 is the zero order administration rate (TK0, time of infusion, 30 min).
A first order model using clearance (CL)
was also fitted to the data in order to determine which of the two models was the better fit. The Schwarz criterion 8 , a measure of the likelihood of fit which accounts for the number of parameters and observations, was used to determine the preferred model. Residual error was described using a power variance model:
where V j is the predicted variance of the jth observation, SD is a scale factor, C j is the predicted concentration, PWR and V0 are model parameters. Fifty Monte Carlo simulations with the same error characteristics as the true estimates were performed using the parameter estimates. The precision and bias of the parameter optimization procedure was determined by comparing these generated estimates with the true parameter estimates 9 .
The parameter values for Vmax and clearance were standardized for a body weight of 70 kg using an allometric power model 10 . 3/4 where X i is the parameter in the ith individual, W i is the weight in the ith individual and X std is the parameter in an individual with a weight W std . Peters 11 has reviewed the evidence that for functional properties of the body such as metabolic rate, a typical power value is 3/4. This parameter is the same for homeotherms, poikilotherms and unicellular organisms. Clearance estimates reported in the literature were reviewed using this allometric 3/4 power model. When applied to physiological volumes such as blood, lung or drug distribution volumes the power parameter 12 is 1.
RESULTS
The model generated concentration time profile for the mixed order model is shown graphically in Figure 1 . The first order plot is demonstrated in Figure 2 . Plots of log concentration vs time for the mixed order ( Figure 3 ) and the first order model (Figure 4 ) demonstrate the non-linearity of the mixed order model. Parameter estimates for the mixed order model are shown in Table 1 . The mixed order model resulted in a better fit than the first order model (Schwarz criterion -23 vs -25.8). Parameter estimates for the first order model are shown in Table 2 . The precision and bias of the prediction method estimated using Monte Carlo simulation are shown in Table 3 .
Literature clearance estimates, standardized to a 70 kg human using the allometric 3/4 power model, are presented in Table 4 . These data are demonstrated graphically in Figure 5 .
DISCUSSION
Theophylline overdose is a well-recognized cause of morbidity in all age groups. When theophylline toxicity is associated with plasma concentrations over 100 mg.l -1 , an ancillary method to increase clearance (enteral charcoal, haemoperfusion, haemofiltration) is usually started. This therapy was not started in this infant because the dosing error was discovered ten hours later, plasma concentrations were decreasing and the infant showed no other manifestations of toxicity aside from tachycardia. It is rare to have the opportunity of studying pharmacokinetics in a toxic patient who has not received adjuvant treatment.
Theophylline clearance increases with maturation 1 12 76 (20) 3.4 (0.9) Child (7 years) 1 22 62 ( of hepatic enzyme systems during early childhood. We report our results standardized to a 70 kg human. The per kilogram model underpredicts clearance by more than 10% in those with body weights under 47 kg 10 . In neonates of 30 to 40 weeks gestation the low clearance is mainly due to urinary excretion of unchanged drug and C-8 oxidation. After 40 weeks gestation demethylation pathways increase, reaching half adult clearance at approximately 55 weeks. Clearance at this age 1,2,13 is 0.9 to 1.9 l.h -1 , a value consistent with our estimate. Between five months and one year clearance is reported to increases dramatically and then decrease slowly to adult values by 16 years 1 . Clearance values have traditionally been reported using the per kilogram model. Standardized clearances (CL std ) do not demonstrate such an obvious trend ( Figure 5 ). A peak of 3.9 l.h -1 .70 kg -1 is reached at one year, but has returned to adult values by two years. Elimination of theophylline is first order when the plasma concentration is very much lower than the Km. The drug concentration declines at a rate directly proportional to its own magnitude. When the plasma concentration approaches the Km, elimination is a function of both the concentration Vmax and the Km. The process is no longer first order. At concentrations much higher than the Km, elimination approaches Vmax. Concentration declines linearly with time. This is zero order elimination 14 .
There are no reports in the literature of Michaelis-Menten parameters for theophylline clearance in children despite recognition that non-linear pharmacokinetics occur at lower toxic concentrations than adults 15 . We estimate a Km of 32.2 mg.l -1 , a value 50% above the upper therapeutic plasma concentration. Weinberger and Ginchesky 16 reported a three-yearold child whose daily theophylline dose was increased from 400 mg to 600 mg. They noted an elimination half-life of 11 hours when plasma concentrations were above 36 mg.l -1 and six hours when below 36 mg.l -1 . The standard error for our Km prediction is large. This prediction value relies on data points at lower plasma theophylline concentrations, of which there were few. The precision and bias of the parameter optimization procedure were low and contributed little to this variance.
There are few data for Vmax and Km parameters in adults. Butts et at 15 estimated a Vmax of 91.7 mg.h -1 and a Km of 67 mg.l -1 in a 62-year-old man with chronic obstructive pulmonary disease. The Km is, as expected, higher than our estimate. This Vmax value is higher than our prediction of 71 mg.h -1 standardized for a 70 kg human. This may be due to the immaturity of hepatic enzyme systems in the infant and the combined effects of smoking and chronic theophylline use causing hepatic enzyme induction in the adult.
The major route of extrahepatic clearance of theophylline is through the renal system. This accounts for 8% of plasma clearance when plasma concentrations are in the therapeutic range. Glomerular filtration is a passive diffusion process and is not saturable. Although theophylline does have diuretic properties this does not explain the magnitude of changes in plasma concentrations associated with dosing changes 4 .
We report a Vd of 0.67 l.kg -1 . This lies between the reported values of 0.86l.kg -1 for a neonate 17 and 0.63 l.kg -1 for a toddler 1 . This decrease is related to body composition changes with age. Total body water and extracellular water in a full-term neonate are 78% and 48% of body weight respectively. Both decrease to adult proportions at 1.5 to 2 years of age. Fat content is 12% at birth, doubles by six months and is 30% of body weight at one year 21 . Skeletal muscle mass and fat tissue are reduced 22 .
The non-linear pharmacokinetics of theophylline have major implications. Clearance values from the literature which have used linear kinetic models overestimate clearance in patients with toxicity. In this child for example, the standardized clearance is only 0.5 l.h -1 when the plasma concentration is 100 mg.l -1 , one third the standardized clearance of 1.67 l.h -1 at 10 mg.l -1 . A knowledge of clearance allows more accurate predictions of the êrequired maintenance dose.
